|
Volume 272, Number 47, Issue of November 21, 1997
pp. 29518-29526
A Mercuric Ion Uptake Role for the Integral Inner Membrane
Protein, MerC, Involved in Bacterial Mercuric Ion Resistance*
(Received for publication, April 22, 1997, and in revised form, August 20, 1997)
Lena
Sahlman
§,
Wendy
Wong
¶ and
Justin
Powlowski
¶
From the Department of Biochemistry, Umeå
University, S-901 87, Umeå, Sweden and the ¶ Department of
Chemistry and Biochemistry, Concordia University, Montreal,
Quebec H3G 1M8, Canada
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Bacterial detoxification of mercuric ion depends
on the presence of one or more integral membrane proteins (MerT and/or
MerC) whose postulated function is in transport of
Hg2+ from a periplasmic Hg2+-binding
protein (MerP) to cytoplasmic mercuric reductase. In this study, MerC
from the Tn21-encoded mer operon was
overexpressed and studied in vesicles and in purified form to clarify
the role played by this protein in mercuric ion resistance.
MerC-containing vesicles were found to take up mercuric ion
independently of MerP. Since uptake correlated with the level of MerC
expression was unaffected by osmotic pressure, and was only partially
decreased in the presence of 0.05% Triton X-100, the observed uptake
appears to represent mainly binding to MerC. Binding was inhibited by thiol-specific reagents, consistent with an essential role for cysteine
residues. The essential thiol groups were inaccessible to hydrophilic
thiol reagents, whereas hydrophobic reagents completely abolished
Hg2+ binding. These observations are consistent with the
predicted topology of the protein, wherein all 4 cysteine residues are
either in the cytoplasm or the bilayer. A role for MerC in
Hg2+ transport is thus also likely. Based on these results,
a modified model for bacterial Hg2+ transport is
proposed.
INTRODUCTION
Bacteria that are resistant to mercuric ions contain a
flavoenzyme, mercuric reductase (MerA), that catalyzes the reduction of
Hg2+ to the volatile and less toxic form, Hg0.
Besides merA, mer operons on the transposons
Tn21 and Tn501 also encompass the genes
merR, merT, merP, merC (which is unique to Tn21),
and merD (1). Both merR and merD
encode proteins involved in the regulation of the operon (2-5). The
other operon-encoded polypeptides are thought to be intimately involved
in the detoxification process, although only the functions of MerA and
MerP have been reasonably well defined at both the genetic and
biochemical levels.
Even before mer operons had been sequenced, it was known
that proteins other than mercuric reductase were involved in mercuric ion resistance. For example, an early observation was that some mercuric ion-resistant bacteria became hypersensitive to
Hg2+ via mutation (6). Hypersensitivity was explained by
postulating the existence of a transport system for mercuric ion:
mutant strains with a functional transport system and a deficient
mercuric reductase pump themselves full of toxic mercuric ions without
being able to reduce Hg2+ to Hg0. Amino acid
sequences deduced from DNA sequences (7-9), combined with minicell
expression experiments (10, 11), suggested that MerP is a periplasmic
protein, and MerT and MerC are integral membrane proteins. This
arrangement is reminiscent of transport systems involving periplasmic
binding proteins, which bind ligands such as maltose and histidine in
the periplasmic space and then interact with one or more integral
membrane transport protein(s) (for reviews, see Refs. 12-14). Such
observations led to the proposal (15) that mercuric ions cross the
outer membrane, bind to MerP, and are transported across the inner
membrane by MerT/MerC to cytoplasmic mercuric reductase (MerA). Upon
reduction of mercuric ion, metallic mercury diffuses out of the cell,
and is removed from the environment of the cell by virtue of its
volatility. Throughout this transport process it has been postulated
that mercuric ion is always bound to pairs of cysteines on the
different transport proteins: data supporting the importance of thiols
has been reported for MerP and MerT (16, 17).
A number of features of the original model have been confirmed by
studying resistance and/or Hg2+ uptake in genetically
manipulated strains, but conflicting data have been reported on the
role of the merC gene product. Deletions of the genes
merT, merC, and/or merP of the
Tn21-encoded system showed that merT and
merP were essential for full resistance (16, 18, 19), but
that merC could be deleted without any effect on resistance,
at least as measured (18). However, in Thiobacillus ferrooxidans there is no gene corresponding to merT,
but rather one that is similar to merC (55% homology at the
amino acid level) (20). Studies of Escherichia coli
expressing merC from T. ferrooxidans indicated
that MerC was involved in the uptake of mercuric ions (21, 22). In the
light of these results, it would be curious if MerC of the
Tn21-encoded system were merely a non-functional bystander.
The ultimate goal of the work in our laboratories is to understand how
the three proteins MerP, MerC, and MerT interact with Hg2+
and each other, and how this interaction brings about the translocation of Hg2+ to mercuric reductase inside the cell. MerP has
already been quite well characterized by ourselves and others (23-26),
but biochemical information about MerT and MerC is lacking. As with
other bacterial membrane transport systems, it will be necessary to
purify the separate components and reconstitute them in artificial
membranes to understand the complete mechanism of Hg2+
detoxification. This paper describes the purification and partial characterization of Tn21-encoded MerC, which appears to be
involved in mercuric ion uptake and binding.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmids
E. coli C600
harboring the plasmid pDU1003 was used for the cloning of
merC. This plasmid contains the mer operon from
plasmid R100 cloned into pBR322 (3). The strain was a gift from Dr. S. Silver, University of Illinois at Chicago. Plasmids generated during
cloning procedures were first introduced into E. coli
strains K12Tc or JM83. The merC gene was
introduced into the vectors pCA (27) or pET3d (28). The vector pET3d
containing the merC insert on an NcoI fragment
will be referred to as pPOW200. E. coli BL21(DE3)pLysS (29)
was used for overexpression of merC from the T7 promoter of
pET3d.
Materials
DEAE-Sepharose Fast Flow, Sephacryl S-200,
isopropyl- -D-thiogalactoside
(IPTG),1 and the Sephaglas
Bandprep kit were purchased from Pharmacia Biotech Inc. All detergents,
and the restriction enzyme NcoI, were purchased from
Boehringer Mannheim. Millipore filters HA, pore size 0.45 µm, were
used in the transport assays. Radioactive mercuric chloride
(203Hg) was purchased from Amersham International. 4-20%
gradient polyacrylamide gels were purchased from Bio-Rad. The
ScreenTest kit for screening for the correct orientation in the plasmid
was obtained from Stratagene. GeneClean was purchased from Biolab 101. The Silver Sequence DNA Sequencing System and Wizard miniprep DNA
purification system were obtained from Promega. Polymerase chain
reaction was conducted using a GeneAmp kit with AmpliTaq polymerase
obtained from Perkin-Elmer. An Amicon stirred cell and filters were
used for protein concentration, while Microsep concentrators came from
Filtron Technology. Benzophenone-4-maleimide and
fluorescein-5-maleimide were purchased from Molecular Probes, Inc., and
bicinchoninic reagent was purchased from Pierce Chemical Co.
N-Ethylmaleimide (NEM), iodoacetic acid, iodoacetamide, and cysteine were obtained from Sigma. Pico-Fluor 40 was purchased from
Packard. Primers for mutagenesis and DNA sequencing were ordered from
Scandinavian Gene Synthesis AB. All other chemicals were of reagent
grade.
DNA Manipulations
DNA manipulations were performed using
standard techniques (30). The plasmid pDU1003 containing the
mer operon from plasmid R100 was used as template for
polymerase chain reaction. The primers used were:
5 -GCGAGAGCCGCTCCATGGGACTGAT-3 (Primer 1) and
5 -TTTGAGGCCCATGGCATCGTTCCTT-3 (Primer 2). Primer 1 is identical to
the coding strand at the start of MerC, bases 1265-1289 (numbered as
in Tn21), except that it introduces an NcoI site
at the ATG start codon. The second primer is complementary to the
coding strand at bases 1740-1767, and also introduces a new
NcoI site at the beginning of the next gene of the operon,
merA. Two rounds of polymerase chain reaction were
performed, and product was cleaved using NcoI and purified using a GeneClean kit. The resulting NcoI fragment was
ligated into the vector pCA followed by transformation into E. coli K12Tc. An insert-containing plasmid was isolated
and after cleavage with NcoI, a 465-base pair DNA fragment
was extracted from an agarose gel using the Sephaglas Bandprep Kit and
inserted at the NcoI site of pET3d. After transformation
into E. coli JM83, plasmids were screened for insert in the
correct orientation using the Screen Test Kit and a
merC-specific primer. Out of 18 screened plasmids, 9 had the
fragment in the correct orientation. One of the plasmids, pPOW200, with
the insert in the correct orientation was sequenced in its entirety,
and agreed at all positions with previously published ones (7, 9).
Expression of MerC
E. coli BL21(DE3)pLysS was
freshly transformed with plasmid pPOW200 each time cells were required.
A single colony was picked, resuspended in LB, and then plated on
LB/agar containing carbenicillin (100 µg/ml) and chloramphenicol (25 µg/ml). After overnight growth at 37 °C, cells from the plate were
suspended in LB containing ampicillin (100 µg/ml) to an
OD600 between 0.1 and 0.2, and grown at 37 °C to an
OD600 of 0.8. At this stage IPTG was added (0.5 mM) and the cells were harvested 2 h later and either
frozen as a paste at 20 °C or used immediately for vesicle
preparations.
Purification of MerC
Cells (6 g wet weight) from 2 liters
of culture were thawed and suspended in 50 mM MOPS buffer,
pH 7.4, containing 0.5 M NaCl (40 ml). Since these cells
produce their own lysozyme, they are very susceptible to lysis. After
thawing out frozen cells and suspending them in buffer, lysis was
complete without further treatment (29). The cell suspension was
incubated at 4 °C for 1 h with DNase (0.01 mg/ml) and
Mg2+ (1 mM). The suspension was then
centrifuged at 200,000 × g for 35 min, and the
supernatant was discarded. The pellet was resuspended in 50 mM MOPS buffer, pH 7.4, containing 0.25 M NaCl
(40 ml). Triton X-100 was added to a final concentration of 0.3%.
After incubation with stirring for 1 h at 4 °C, the suspension
was centrifuged as above, and the pellet was discarded. The remaining
43 ml of supernatant was diluted with 172 ml of 10 mM
Tris-Cl buffer, pH 8.0, containing 0.3% Triton X-100 and then applied
to a DEAE-Sephadex Fast Flow column equilibrated in 25 mM
Tris-Cl buffer, pH 8.0, containing 50 mM NaCl and 0.3%
Triton X-100. The column was washed with the equilibration buffer.
Fractions were collected and analyzed on polyacrylamide gels for the
presence of MerC. MerC eluted with the sample application and wash.
Fractions containing MerC were pooled and concentrated on a YM5
ultrafilter. The concentrated sample was applied to a Sephacryl S-200
gel filtration column which had been equilibrated in 25 mM
MOPS buffer, pH 7.4, containing 75 mM NaCl and 0.3% Triton
X-100. Fractions containing MerC were pooled and concentrated and
frozen at 50 °C until further use. MerC purification was also
carried out using buffers containing 1 mM cysteine, which
has been found to keep thiol groups reduced during purification of MerP
(23).
Preparation of Vesicles
E. coli BL21(DE3)pLysS
harboring either pPOW200 (expressing merC) or pET3a (vector
control) were grown and induced using IPTG as described above. E. coli BL21(DE3)pLysS were transformed with the plasmid pDU1003 and
grown on LA plates containing chloramphenicol (25 µg/ml) and
tetracycline (10 µg/ml). Single colonies were suspended in LB and
replated: after overnight growth, colonies from one plate were
suspended in 400 ml of LB broth containing tetracycline (10 µg/ml)
and grown to OD600 = 0.9. At this point expression from the
mer operon was induced by the addition of Hg2+
(20 µM). Since Hg2+ is volatilized during
further growth, another addition of Hg2+ (10 µM) was made after 1 h. Samples of cells were
harvested before induction and at 20 and 80 min after the start of
induction.
Vesicles were prepared according to a method based on that described by
Kaback (31). Thus, the procedure of Witholt et al. (32) was
used for making spheroplasts, followed by vesicle preparation described
by Kim et al. (33), except the preparation buffer was
Tris-Cl, pH 8.0, instead of 7.5. The relative concentrations of
vesicles were estimated by measuring the optical density at 550 nm. The
relative amounts of MerC present in vesicles were estimated by scanning
a polyacrylamide SDS gel using a LKB 2202 Ultroscan laser
densitometer.
Analytical Techniques
A Perkin-Elmer 320 spectrophotometer
was used for UV visible absorbance measurements.
Gradient gels (4-20%) (34) were used to analyze for the presence of
MerC. Samples were incubated at 40 °C in SDS-polyacrylamide gel
electrophoresis sample buffer for 30 min before application to gels.
Protein concentrations were determined using the bicinchoninic acid
assay, as described by Smith et al. (35). Amino-terminal sequencing was performed by Dr. P.-I. Ohlson, Dept. of Medical Chemistry, University of Umeå.
The number of accessible thiol groups in purified MerC was estimated
using 5,5 -dithiobis(2-nitrobenzoic acid) according to previously
described methods (36). Determinations were carried out in 0.1 M sodium potassium phosphate buffer, pH 7.27, 1 mM EDTA, and in this buffer containing guanidine
hydrochloride (5.8 M). 0.07 M Tris-Cl, pH 8.0, 1 mM EDTA, was used when the determination was carried out
in the presence of sodium dodecyl sulfate (2%). Excess cysteine in
preparations of MerC that contained it was removed by filtration
through a small Sephadex G-25 column, equilibrated in 25 mM
Tris-Cl, pH 8.0, containing 75 mM NaCl and 0.3% Triton X-100. Thiol determinations were also carried out on samples of MerC
that had been reduced using dithiothreitol: excess reducing agent was
removed by Sephadex G-25 chromatography in 25 mM MOPS buffer, pH 7.4, containing 75 mM NaCl, 0.3% Triton X-100,
and 1 mM EDTA.
Hg2+ Uptake Assays
Uptake of Hg2+
by vesicles was measured by following the incorporation of
radioactively labeled Hg2+. These assays involved
incubation of vesicles in 50 mM Tris-Cl buffer, pH 7.3 or
8.0, for 1 min at room temperature. Hg2+ and cysteine in a
1:4 ratio, also containing 203Hg2+, were then
added. At various times, samples of 0.5 or 1.0 ml were loaded by vacuum
onto a filter (0.45 µm) and washed with 1.0 ml of 50 mM
Tris-Cl, pH 7.3. The filters were counted in Pico-Fluor scintillation
(4 ml) fluid in a LKB-Wallac liquid scintillation counter 1214 Rackbeta. Approximately 30% of the vesicle protein typically washed
through the 0.45-µm filter. No adjustment was routinely made for
this. When transport was measured in the presence of thiol-modifying
reagents, vesicles were preincubated for 10 min or 1 h at room
temperature, in the dark with NEM, benzophenone-4-maleimide, fluorescein-5-maleimide (1 mM), or
iodoacetamide/iodoacetate (10 mM).
Hg2+ Binding Assay
Binding of Hg2+
to purified MerC was measured in potassium phosphate buffer, pH 7.3, with Hg2+ and cysteine, in a ratio of 1:4. The substrate
solution was mixed 1:1 with purified MerC in a Microsep concentrator,
cutoff 3000 Da, which was centrifuged for 15 min at 4400 × g. The concentrations of Hg2+ in the upper and
lower reservoir were measured and the amount bound to the protein was
calculated using the method previously described (23). Purified MerC
used in the assay was first preincubated with a 30-fold excess of DTT
for 1 h at room temperature. The protein was separated from the
DTT by gel filtration on a Sephadex G-25 column prior to the
binding assay.
RESULTS
Cloning and Overexpression of MerC
The gene merC
was introduced into the T7 promoter-based expression plasmid, pET3d,
and expressed in E. coli BL21(DE3)pLysS, as described under
"Experimental Procedures." By running samples of the insoluble
fractions of cells harvested from uninduced and induced cultures on
polyacrylamide gels, it was possible to identify a band corresponding
to MerC (Fig. 1, lanes 1 and
2). Compared with the molecular mass standards, MerC
migrated at a molecular mass corresponding to 15 kDa, which agrees well
with that (14.8 kDa) predicted from the amino acid sequence.
Fig. 1.
Overexpression and purification of MerC.
SDS-polyacrylamide gradient gel, 4-20%. Lane 1, uninduced
cells; lane 2, cells induced with IPTG; lane 3, supernatant after cell lysis and first centrifugation; lane
4, pellet after cell lysis and first centrifugation; lane
5, Triton X-100 extract of pellet; lane 6, remaining
pellet after Triton X-100 extraction; lane 7, concentrated
DEAE-Sepharose fraction; lane 8, concentrated Sephacryl
S-200 fraction.
[View Larger Version of this Image (75K GIF file)]
Uptake of Mercuric Ions by Vesicles and Inhibition by
Thiol-specific Reagents
Vesicles were prepared from E. coli BL21(DE3)pLysS harboring the merC expression
plasmid, pPOW200, or the vector control, pET3a. Uptake of radioactively
labeled mercuric ions by these vesicles was measured in the presence of
a 4-fold excess of cysteine to minimize nonspecific interactions (Fig.
2A). There is clearly a
difference between vesicles containing MerC and the control lacking
MerC. In the experiment shown, uptake in MerC vesicles was
approximately 6 times higher than in the pET3a vesicles, and was
generally between 5- and 8-fold higher in different experiments.
Fig. 2.
Uptake of Hg2+ by vesicles.
Uptake was measured at room temperature in 50 mM Tris-Cl
buffer, pH 7.3, containing HgCl2 (1 µM) and
cysteine (4 µM). Samples (1 ml) were removed at 0.5, 1, 5, and 15 min onto a filter. A: , uptake in MerC
vesicles. , uptake in MerC vesicles preincubated for 1 h with 1 mM NEM. , uptake in pET control. , uptake in pET
vesicles preincubated for 1 h with NEM. B, uptake in
MerC vesicles after 15 min following preincubation for 1 h with 1 mM NEM, 10 mM iodoacetamide, 10 mM iodoacetate, or in 50 mM Tris-Cl buffer, pH 8.0.
[View Larger Version of this Image (16K GIF file)]
In the experiments described above the total concentration of
Hg2+ was 1 µM, while the amount taken up by
the vesicles was 60%, or 11 nmol of Hg2+/mg of protein.
Considering that up to 30% of the vesicles were typically lost in the
filtration process, it is possible that all of the Hg2+ was
taken up and therefore may have been limiting. However, when the
concentration of Hg2+ was increased to 10 µM,
the total amount of Hg2+ taken up by the vesicles was the
same (data not shown), so this does not appear to be the case.
Since MerC contains two pairs of cysteine residues,
Cys22-Cys25 and
Cys127-Cys132, and cysteines have high affinity
for mercuric ions, the effects on Hg2+ uptake of the
membrane-permeable thiol-modifying reagent, N-ethylmaleimide (NEM), were also examined. As is shown in Fig. 2A, uptake of
Hg2+ was completely inhibited by preincubation of the
vesicles with NEM (1 mM), indicating that cysteine residues
are indeed important for the observed uptake. By contrast, inhibition
by the hydrophilic thiol modifying reagents, iodoacetate and
iodoacetamide (10 mM), was much less complete in the same
time period (Fig. 2B). Since NEM is membrane permeable,
these results suggested that the essential cysteines are not accessible
on the periplasmic side of the membrane.
Thiol accessibility has been probed in other membrane proteins using
hydrophobic benzophenone-4-maleimide and hydrophilic fluorescein-5-maleimide to distinguish between surface-accessible and
thiol groups buried in the membrane (37). The effects of these reagents
on uptake of Hg2+ by MerC-containing and control vesicles
are shown in Fig. 3. While the
hydrophilic reagent inhibited the uptake in MerC and control vesicles
by approximately 30%, practically all uptake was abolished in the MerC
vesicles treated with the hydrophobic reagent. The hydrophobic reagent
will pass into the membrane and thus modify cysteine residues located
in the membrane, or close to it on the cytoplasmic side. These results
strongly suggest that the essential cysteine residues of MerC are not
accessible on the periplasmic surface.
Fig. 3.
Uptake of Hg2+ in the presence of
benzophenone-4-maleimide and fluorescein-5-maleimide by MerC containing
and control (pET) vesicles. Uptake was measured as in Fig. 2,
after preincubation for 10 min in the presence of buffer, 1 mM benzophenone-4-maleimide (BM), or 1 mM fluorescein-5-maleimide (FM). The data shown
represents uptake after 15 min.
[View Larger Version of this Image (33K GIF file)]
Uptake by Vesicles with Varying Levels of MerC
Although MerC
was clearly responsible for Hg2+ uptake, it was not clear
whether the uptake exemplified by Fig. 2 represents transport to the
vesicle interior or whether it represents binding to the overexpressed
MerC located in the cell membrane. If it is the former, the level of
uptake should be independent of the amount of MerC in the membrane,
whereas in the case of binding, the observed uptake should depend on
the amount of MerC present. To prepare vesicles with varying levels of
MerC, samples of E. coli BL21(DE3)pLysS harboring pPOW200
were harvested just before induction (t = 0), and at
30, 60, and 120 min, respectively, after the addition of IPTG. Vesicles
were prepared and samples of them were run on an SDS-polyacrylamide gel
to confirm the amount of MerC present at different time points: the
amount of MerC increases with the induction time (Fig.
4A). The protein migrating at
the position of MerC in the uninduced sample (Fig. 4A, lane
2) may either be a normal E. coli protein, since it is
present even in a strain lacking merC altogether, or it may
represent the basal expression level of MerC (29). Laser densitometry
of the gel shown in Fig. 4A revealed that MerC present in
vesicles from cells induced for 0, 30, 60, or 120 min represented 1, 6, 9, and 8% of total protein, respectively.
Fig. 4.
Uptake of Hg2+ by vesicles
containing different levels of MerC. Vesicles were prepared from
bacteria where the production of MerC had been induced for 0, 30, 60, and 120 min, respectively. A, 4-20% gradient
SDS-polyacrylamide gel showing MerC in vesicles produced from cells
induced for different times. The amount of sample loaded was correlated
to the OD550 of the vesicle preparations, so that equal
amounts of vesicles were loaded. Lane 1, purified MerC;
lane 2, uninduced vesicles; lanes 3-5, vesicles
from cells induced for 30, 60, and 90 min, respectively. B,
uptake of Hg2+ in vesicles from cells induced for 0 ( ),
30 ( ), 60 ( ), or 120 ( ) min. Uptake was measured as described
in the legend to Fig. 2.
[View Larger Version of this Image (27K GIF file)]
Results of Hg2+ uptake assays using these vesicles are
shown in Fig. 4B. The vesicles were diluted for the uptake
assay so that the relative concentration of vesicles, as judged from
the OD at 550 nm, was the same. From these data it is clear that the uptake level is dependent on the amount of MerC present in the vesicles. This indicates that Hg2+ remains bound to MerC,
rather than being released into the interior of the vesicle. The total
amount of protein was measured and the amount of MerC in picomoles was
calculated using the data from the gel shown to estimate mole of
Hg2+ bound per mol of MerC. This value varied between 1.3 and 2.6 Hg2+ per MerC, regardless of whether the total
concentration of Hg2+ was 1 or 10 µM, and
this too is consistent with uptake and binding to MerC rather than
uptake and release.
Influence on Hg2+ Uptake of Electrochemical Gradient,
Osmotic Pressure, and Detergent
To probe the nature of
Hg2+ uptake further, the ability of MerC-containing
vesicles to take up mercuric ions under other conditions were examined.
First, MerC vesicles were preincubated with 20 mM potassium
ascorbate, pH 6.8, and 10 µM phenazine methosulfate in 50 mM potassium phosphate buffer, pH 7.3. These conditions have been shown to drive numerous other periplasmic
protein-dependent transport systems by creating an
electrochemical gradient across the membrane and/or generating ATP
inside vesicles (13, 38). Preincubation under these conditions did not
increase the observed uptake of Hg2+ (Fig.
5). Vesicles were also preincubated in
Tris-Cl buffer, pH 7.3, containing sucrose (0-1 M). Under
conditions of increased osmotic pressure one would expect to see
decreased uptake, if Hg2+ were transported across the
membrane and released into the interior, as has been observed for
histidine uptake (38). However, there was no effect of increasing
sucrose concentrations on the uptake of mercuric ions (Fig. 5).
Finally, vesicles were also preincubated for 1 h with 0.05%
Triton X-100. This treatment should render the vesicles leaky, so that
any substance released into the vesicle interior could leak out again.
The Triton X-100-treated vesicles exhibited reduced Hg2+
uptake, to about 60% of that shown by vesicles not treated with Triton
X-100, but still 4 times higher uptake than the control vesicles (Fig.
5). All these data provide further evidence that Hg2+ is
not transported across the membrane and released, but rather that the
ions remain bound to MerC in the vesicle membrane.
Fig. 5.
Dependence of Hg2+ uptake by
vesicles on various additives. Vesicles were preincubated for 1 min in 50 mM potassium phosphate buffer, pH 7.3. Vesicles
were also preincubated with either 10 µM phenazine
methosulfate and 20 mM potassium ascorbate, pH 6.8, or the
other additives indicated. Uptake of Hg2+ was measured as
described in the legend to Fig. 2, except that the buffer was 50 mM potassium phosphate, pH 7.3. The amount taken up after
15 min is shown.
[View Larger Version of this Image (42K GIF file)]
Purification of MerC
MerC was purified both in the presence
and absence of cysteine, as described under "Experimental
Procedures." After cell breakage and ultracentrifugation MerC was
found in the membrane fraction (Fig. 1, lanes 3 and
4), so initially several different detergents were tested
for their ability to solubilize it. Tween 20, n-octyl glucoside, CHAPS, and deoxycholate all solubilized MerC poorly (data
not shown), whereas both Nonidet P-40 and Triton X-100 gave good and
relatively selective solubilization (Fig. 1, lanes 5 and
6). N-Dodecyl- -D-maltoside also
solubilized MerC, but was not as selective. Triton X-100 was therefore
chosen as the most suitable detergent. Since extraction using Triton
X-100 was done at a high salt concentration, this solution had to be
diluted before application to the DEAE column. Following this column, a
gel filtration step was performed, after which MerC appeared to be
essentially pure, as judged by SDS-polyacrylamide gel electrophoresis (Fig. 1). The yield from 2 liters of culture was approximately 30 mg.
A sample of purified protein was submitted for determination of the
amino-terminal sequence, and the result, Gly-Leu-Met-Thr-Arg, was as
expected from the DNA sequence with the initial Met cleaved off. No
contaminating proteins were detected during the sequencing cycles.
Properties of Purified MerC
To examine the possibility of
disulfide-bonded multimer formation, samples of purified MerC were
treated with SDS gel mixture in the presence or absence of
-mercaptoethanol. From the gel shown in Fig.
6 it is clear that under nonreducing
conditions the protein exists as a dimer as well as a monomer
(lanes 1 and 2) while under reducing conditions
almost none of the MerC is dimeric (lanes 5 and
6). MerC that had been purified in the absence of the reducing
agent, cysteine, had one-third of MerC in the form of the dimer, while
MerC that had been purified with cysteine in the buffers contained
twice as much dimer as monomer (compare lanes 1 and
2, Fig. 6). When the samples were incubated with DTT for
1 h at room temperature (see below), and freed of excess DTT by
gel filtration, most of the MerC ran at the position of the monomer
(data not shown). Taken together, these data indicate that some MerC as
purified is a disulfide-bonded dimer. The difference in the proportions
of dimer and monomer from the different preparations indicates that the
cysteines participating in the dimer formation are sensitive to
oxidation. Apparently the presence of cysteine facilitates the
formation of intermolecular disulfide bonds, perhaps via intermediate
formation of a mixed disulfide with one or more cysteine residues of
MerC.
Fig. 6.
SDS-polyacrylamide gel electrophoresis of
purified and vesicular MerC under oxidizing or reducing
conditions. 4-20% gradient SDS-polyacrylamide gel. Samples in
lanes 1-4 were treated with SDS sample mixture without
-mercaptoethanol, and samples in lanes 5-8 were treated
with SDS mixture containing -mercaptoethanol. Lanes 1 and 5, MerC purified in the absence of cysteine;
lanes 2 and 6, MerC purified in the presence of
cysteine; lanes 3 and 7, vesicles from cells
expressing MerC; lanes 4 and 8, vesicles from
cells containing the pET control vector (no MerC expressed). The
arrow shows the location of the dimer of MerC.
[View Larger Version of this Image (70K GIF file)]
Since oxidation of MerC during purification might be the cause of
dimerization, the existence of disulfide-bonded dimer was also examined
in vesicle samples. Vesicles were treated with SDS sample mixture with
or without -mercaptoethanol, and run on an SDS-polyacrylamide gel
(Fig. 6, lanes 3, 4, 7, and 8). As can be seen, MerC exists partially as a dimer in the vesicle preparations as well, but the ratio of monomer to dimer is considerably higher, approximately 4:1. Therefore, handling during purification appears to
exacerbate dimer formation. We cannot exclude the possibility that the
dimers are formed in vesicles because there is so much MerC present in
the membrane in this overexpressing system, and that MerC expressed at
wild-type low levels would mainly exist as a monomer. However, to
detect MerC monomers and dimers at the lower expression levels in the
native strains, it will be necessary to obtain MerC-specific
antibodies.
Thiol Group Determinations
The amino acid sequence predicts
the existence of four cysteines in MerC. The number of accessible thiol
groups in MerC purified in the presence and absence of cysteine was
therefore examined using 5,5 -dithiobis(2-nitrobenzoic acid). No thiol
groups of MerC reacted with 5,5 -dithiobis(2-nitrobenzoic acid) in
native, guanidinium hydrochloride (5.8 M), or SDS
(2%)-treated samples. After incubation at room temperature for 1 h with a 20-fold excess of DTT, followed by removal of excess reducing
agent, MerC preparations showed 1.7-1.9 thiol groups/protein.
SDS-polyacrylamide gel electrophoresis analysis (see above) indicated
that these samples were mostly monomeric. Therefore, the other two
thiols may either be inaccessible to DTT, or to the bulky DNTB
molecule.
Binding of Mercuric Ions to Purified MerC
Data collected
using vesicles strongly suggested that uptake of Hg2+
represents binding to MerC in the membrane. Therefore the binding properties of purified MerC were studied using the same assay that was
developed for binding studies of MerP (Fig.
7). These binding studies were performed
in the presence of a cysteine to Hg2+ ratio of 4:1, so that
nonspecific binding like that observed with MerP in the absence of
cysteine should be avoided (23). MerC that had been prereduced with DTT
can clearly bind Hg2+ (Fig. 7). However, in contrast to the
binding data obtained with MerP, the data for MerC could not be fitted
well to an equation describing binding to one site. Thus it seems as if
either binding is more complex than simple binding to one site, or that
the method is not suitable for measurement with MerC in Triton X-100
micelles.
Fig. 7.
Binding of Hg2+ to purified
MerC. Binding was measured in 50 mM potassium
phosphate buffer, pH 7.3, with Hg2+ and cysteine, at a
constant ratio of 1:4. Purified MerC was preincubated with a 30-fold
excess of DTT for 1 h at room temperature, whereupon the DTT was
removed by gel filtration. The substrate solutions were mixed 1:1 with
20 µM MerC in a Microsep concentrator which was
centrifuged for 15 min. The concentrations of Hg2+ in the
upper and lower reservoir was measured and the amount bound to the
protein was calculated.
[View Larger Version of this Image (15K GIF file)]
Prediction of MerC Topology
The TopPred II (39) program was
used to predict the topology of MerC. This program uses an algorithm
that takes into account the hydrophobicity of amino acid residues as
well as the "positive inside" rule (40), which has been found to be
very effective in predicting the topology of bacterial inner membrane
proteins. The predicted model for MerC is shown in Fig.
8, where the amino acids are numbered
assuming that the initial methionine has been cleaved off. This model
places the two cysteine residues 22 and 25 at the amino-terminal end of
the first -helix, while the remaining two cysteines, 127 and 132, are in a loop on the cytoplasmic side. Thus all four cysteine residues
are predicted to be on or near the cytoplasmic side of the inner
membrane which would mean that there are no cysteine residues on the
periplasmic side that can pick up Hg2+. This prediction is
in agreement with the data using thiol modifying agents. No other amino
acid residues, such as histidine, which have high affinity for
Hg2+ are predicted by this model to be located on the
periplasmic side.
Fig. 8.
Predicted topology of MerC. There are 4 predicted transmembrane helices, with 9 lysines and arginines on the
inside and one on the outside. Starting from the amino-terminal, the helices are comprised of: residues 21-41, residues 51-71, residues 77-97, and residues 100-120.
[View Larger Version of this Image (25K GIF file)]
Effects of MerP on Uptake
In other systems with periplasmic
binding proteins, the transported compound is not transferred across
the inner membrane in the absence of the binding protein (12-14).
Therefore, the effects of added MerP on the uptake of Hg2+
by MerC-containing vesicles were examined. As can be seen in Fig.
9, 30 µM MerP inhibited
Hg2+ uptake to 6.4% of the uptake observed in the absence
of MerP. Considering that the Kd for MerP is 2.8 µM Hg2+, and the total concentration of
Hg2+ in this experiment was only 1 µM, it
appears that Hg2+ remained associated with MerP rather than
being transferred to MerC. Therefore uptake of Hg2+ was
also measured in the presence of only 0.3 µM MerP and was found to be 92% of that observed in the absence of MerP, which is
within the margins of error. Thus, MerC has a high enough affinity for
Hg2+ so that in the periplasm at least some
Hg2+ can be transferred to MerC even in the presence of
MerP. However, MerP is not necessary for MerC-mediated mercuric uptake,
and depending on the relative concentrations may in fact inhibit
it.
Fig. 9.
Hg2+ uptake by vesicles in the
presence of MerP. Uptake was measured in vesicles containing MerC
and in control vesicles lacking MerC. Uptake was measured as described
in the legend to Fig. 2, either in the absence of MerP or in the
presence of 0.3 or 30 µM MerP.
[View Larger Version of this Image (46K GIF file)]
Hg2+ Uptake in Vesicles Containing MerT and
MerC
Although MerP is not necessary for MerC-mediated
Hg2+ uptake, perhaps MerT plays a crucial role
since in the Tn21-encoded system membrane-bound MerT and
MerC are produced together. To test this question, vesicles were
prepared from E. coli BL21/DE3pLysS harboring the plasmid
pDU1003, which encodes the complete Hg2+-inducible
mer operon (3). Hg2+ uptake was measured in
vesicles prepared from cells induced for 0, 20, and 80 min,
respectively. As can be seen in Fig.
10, uptake in vesicles prepared from
induced versus uninduced cells was approximately 3.8-fold
higher. Uptake was also measured in the presence of 100 mM
NaCl, since it has been suggested that Hg2+ may be
co-transported with a sodium gradient (41). There was no difference
between uptake in the absence or presence of NaCl (Fig. 10).
Preincubation with phenazine methosulfate and ascorbate did not
significantly change the measured Hg2+ uptake, as was
observed with vesicles containing only MerC (see above), nor was uptake
increased in the presence of MerP (data not shown). The total amounts
of Hg2+ taken up by these vesicles were 1.26, 4.78, and
4.00 nmol/mg of protein, for the vesicles induced for 0, 20, and 80 min, respectively. These values are approximately 3-fold lower than the
corresponding values for the MerC-containing vesicles. It is important
to note, therefore, that the levels of MerC and MerT present in these
vesicles are much lower than in the vesicles from the cells
overexpressing MerC (data not shown). Although the total uptake of
Hg2+ in these vesicles was approximately 3-fold lower than
that observed in the vesicles containing only MerC, the difference
between uptake in vesicles prepared from induced versus
uninduced cells is quite similar. We have also obtained similar results
using vesicles prepared from cells overexpressing only
MerT.2 Therefore the results
obtained using the vesi-cles containing only MerC do not appear to
reflect the fact that MerT is absent.
Fig. 10.
Uptake by vesicles containing MerC and
MerT. Uptake was measured in vesicles prepared from bacteria
harvested 0 ( ), 20 ( ), or 80 min ( ) after induction with
HgCl2, (unfilled symbols). Uptake was also
measured in the presence of 100 mM NaCl (filled symbols). The conditions are as described in the legend to Fig. 2.
[View Larger Version of this Image (19K GIF file)]
DISCUSSION
Bacterial detoxification of mercuric ion has been postulated to
include a mercuric ion transport system comprising the periplasmic protein, MerP, and the membrane proteins, MerC and/or MerT. In the
Tn501-encoded system, which lacks merC, deletion
analysis indicated that MerP and MerT were both necessary for full
resistance (19), but MerT alone was apparently sufficient for mercuric ion transport (16). On the other hand, studies of MerC from T. ferrooxidans, which lacks both MerT and MerP,
link Hg2+ uptake by whole cells to the presence of MerC
(21, 22). Therefore, it appears that either MerC or MerT can facilitate
mercuric ion uptake, but in neither case has mercuric ion transport
been characterized at the biochemical level.
The Tn21-encoded mercuric ion resistance operon is
complicated by the existence of both merC and
merT. In a study of the roles of the different
Hg2+-resistance proteins in the Tn21 system,
construction of deletion mutants showed that both merT and
merP were necessary for full resistance to 50 µM Hg2+: deletion of merT had a
greater impact than deletion of merP (18). Mutants lacking
only merC still showed uptake of Hg2+, but upon
deletion of only merT, uptake of Hg2+ ceased
suggesting that only merT is essential. However, since these
studies used single-copy plasmids and protein expression was not
quantitated, it is possible that the levels of MerC expression were not
high enough in these strains to detect uptake. These data thus do not
rule out the involvement of MerC in mercuric ion uptake in the
Tn21-encoded system, a role which might be expected based on
the observation that merC is the only membrane
protein-encoding gene present in some mer operons.
Our data clearly show that Tn21-encoded MerC mediates
specific Hg2+ binding. None of the collected evidence was
consistent with a role for MerC as a channel protein that allows
Hg2+ to flow unrestricted into the cytoplasm. Rather, the
lack of energy dependence, the fact that uptake was unaffected by
osmotic pressure, and the observation that the amount of MerC present in the vesicles affected the level of Hg2+ uptake, all
indicate that mercuric ion is taken up and remains bound to
MerC.
Little attempt has previously been made to distinguish between the flow
of Hg2+ into the cytoplasm of resistant bacteria and the
type of controlled binding we observed for MerC. However, nothing in
previously published data supports the idea that MerC or MerT function
as channel proteins. For example, Nakahara et al. (6) found
that Hg2+ uptake was not inhibited by toluene treatment,
detergent treatment, or even heat treatment. These observations are not
consistent with the existence of Hg2+ conducting channel
proteins, but support the idea that the membrane proteins bind
Hg2+. In studies where the amounts of Hg2+
taken up by cells have been quantitated, the levels of mercuric ions
that get incorporated are all low relative to appropriate controls.
Thus, the difference in Hg2+ uptake between induced and
uninduced cells harboring the Tn21 encoded uptake system was
approximately 3-fold (6, 18), when the total concentration of
Hg2+ was 2 µM. In two different studies of
uptake in Thiobacillus, a 2- (21) or 5-fold (22) difference
between induced and uninduced cells was reported where the total
concentrations of Hg2+ were 5 and 2.5 µM,
respectively. These differences in uptake levels are similar to those
observed in this study (Fig. 2).
A crucial point is therefore where the Hg2+-binding site is
located in MerC. According to the predicted membrane topology of MerC,
two pairs of cysteine residues are both located on the cytoplasmic side
of, or in, the membrane. Inhibition of MerC-dependent
uptake by thiol reagents supports the notion that cysteine residues are important. Uptake of Hg2+ complexed to cysteine was
completely inhibited in the presence of the membrane-permeable
sulfhydryl reagent, NEM (Fig. 2), and the hydrophobic
benzophenone-4-maleimide (Fig. 3). By contrast, there was little
inhibition observed using the hydrophilic reagent fluorescein-5-maleimide (Fig. 3) or 10-fold higher concentrations of
the hydrophilic thiol reagents, iodoacetate and iodoacetamide (Fig.
2B). These data are all consistent with the essential thiols being located either within the membrane bilayer, or close to it on the
cytoplasmic side, as predicted by the computer analysis (Fig. 8). These
results therefore rule out the possibility that MerC simply binds
nonspecifically to accessible thiols on the periplasmic surface, and
imply that MerC can mediate transport through the bilayer: however, in
the absence of a driving force (see below), Hg2+ remains
bound to MerC.
The amino acid sequence GMXCXXC has been proposed
to be a consensus heavy metal binding motif, and is present in MerP,
where it has been correlated with specific binding of Hg2+
(24, 26), as well as in proteins transporting copper and cadmium (42).
This motif is also present in the amino-terminal region of mercuric
reductase but does not appear to affect the enzymatic activity (43): it
is not known whether it mediates Hg2+ binding. The presence
of a nearly identical sequence in MerC around Cys22 and
Cys25 suggests that these residues are the ones involved in
mercuric ion binding. Interestingly, these residues are predicted to
lie near or in the bilayer. In contrast, MerT does not have this
sequence, suggesting that if it binds Hg2+, it may do so in
a different mode possibly involving MerT multimers as suggested by
Brown and co-workers (16, 17). Indeed, it is difficult to imagine how
the amino-terminal cysteine pair could bind Hg2+ in a MerT
monomer, since the two residues are adjacent to each other in a
proposed transmembrane helix.
Most membrane transport proteins are rather large: the maltose
transporter appears to consist of two proteins, with 6 and 8 -helices each (14) and the lac permease has 12 -helices (44),
whereas MerC and MerT only have four and three (16) predicted
-helices, respectively. It is, of course, possible that either or
both of these proteins forms dimers or other multimers in the
membrane, and that these are the functional units. Our preparations of
MerC show that there is indeed some dimerization due to intermolecular
disulfide bonding, but we cannot rule out the possibility that this
results from the high expression levels achieved in the strains
studied. In wild-type cells where MerT is also present, MerC molecules
might interact with MerT, thus limiting the interaction between MerC
molecules. Since we detected no substantial differences in
Hg2+ uptake behavior when both proteins were expressed,
present evidence indicates that physical interaction between MerC and
MerT is not essential for Hg2+ uptake by MerC. The question
of the quaternary structures of MerC and MerT needs to be more fully
examined in the future, however.
An important observation was that MerP appears to have no required role
in transfer of Hg2+ across the membrane. Uptake in
MerC-containing vesicles was not increased in the presence of MerP, nor
was uptake by the MerC-MerT containing vesicles from cells harboring
the complete operon increased in the presence of MerP. This is in
marked contrast to periplasmic binding-protein dependent systems
(e.g. for amino acid uptake), and conflicts with a widely
accepted model for Hg2+ detoxification (15): in these cases
the periplasmic protein initially accepts the ligand and transfers it
to membrane-bound transport proteins. A reasonable conclusion is
therefore that instead, MerP primarily acts as a scavenger, binding
Hg2+ and keeping it away from other periplasmic proteins
which require thiol groups for activity, as has been suggested by
Summers (45). This interpretation is also in agreement with genetic
data which inferred that MerP is not necessary for MerT-mediated
Hg2+ uptake (16, 18). However, by default, MerP-bound
Hg2+ may still be the main periplasmic source of any
mercuric ion transferred to MerC and/or MerT.
How, then, does Hg2+ pass through the membrane, if not by a
periplasmic binding protein-mediated process? Two possibilities for
Hg2+ passage through the inner membrane are diffusion
through the bilayer, and passage via MerC and/or MerT. Studies have
shown that phospholipids interact with Hg2+ and that
membranes are permeable to HgCl2 (46, 47), but no studies
have been made using Hg2+ coupled to thiols. Since thiol
ligation of Hg2+ tends to supress nonspecific (weaker)
interactions (e.g. Refs. 23 and 48), our experiments were
always carried out in the presence of a 4-fold excess of cysteine. If
transfer of this complex across the membrane occurs passively, it must
be very slow since uptake by control vesicles was relatively low, and
could as easily represent surface binding as transport. The observation
that MerC binds mercuric ion via surface-inaccessible thiols strongly
suggests that this protein has a role in actual transfer across the
membrane, in addition to its binding function. If so, what drives the
release of Hg2+ from MerC? Considering the metal-binding
consensus sequence at the amino terminus of mercuric reductase, and its
homology to MerP, it is likely that Hg2+ does indeed bind
there, prior to transfer to the active site for reduction. Transfer of
Hg2+ from MerC to the amino-terminal thiols of mercuric
reductase thus may provide the "trigger" for release of mercuric
ion from MerC: such a trigger is not present in the vesicles used in
this study. The release of Hg2+ to mercuric reductase, and
its reduction, would provide the driving force for transport in a
bacterium harboring all of the proteins necessary for Hg2+
resistance.
Taking these data together, a revised model for the Hg2+
detoxification system encoded by Tn21 may be proposed. Of
the 5 structural genes encoded by the operon, we propose that three are
Hg2+-binding proteins, namely MerP, MerC, and the
amino-terminal region of mercuric reductase. This assertion is based on
the existence of the heavy metal consensus binding sequence,
GMXCXXC, in these proteins, as well as the
demonstrated binding properties of MerP (24, 26) and MerC (described in
this paper). With specific Hg2+-binding proteins in the
periplasm, inner membrane, and cytoplasm, Hg2+ would always
be sequestered to a protein, minimizing interaction with other cellular
proteins in these compartments. In the event that Hg2+
actually did get into the cytoplasm, it would do so via MerC (or MerT)
and be intercepted by mercuric reductase. Thus, a crucial difference
between this and earlier models is that although MerP/MerC/MerT participate in transport they are not designed to maximize transport of
Hg2+ into the cell. Although MerT is clearly important for
uptake in vivo and may supplement or complement MerC in the
Tn21 system, further studies are required to define the
molecular mechanism of MerT in this system.
If the transport proteins do not permit unrestricted flow of
Hg2+ into the cell, why are bacteria lacking functional
mercuric reductase hypersensitive to Hg2+ (6)? In our
experiments, vesicles are devoid of cytoplasmic proteins so there is
nothing to compete with the binding sites on MerC for Hg2+.
However, although Hg2+ binds tightly to thiols, there is
also rapid equilibrium with other thiols (48), so in a wild-type cell
it is possible that enough mercuric ions are leached off MerC to
produce the toxic effects seen as bacteria are growing. However, when
mercuric reductase is present a specific transfer mechanism, followed
by reduction of Hg2+, may protect cytoplasmic proteins from
interaction with mercuric ions. Perhaps the biggest unknown question is
how Hg2+ can be released from MerC to mercuric reductase in
the cytoplasm, and that question is currently under investigation in
our laboratories.
FOOTNOTES
*
This work was supported by grants from the Magnus Bergvalls
Stiftelse (to L. S.) and the Natural Sciences and Engineering Research Council of Canada (to J. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 46-90-786-6974;
Fax: 46-90-786-7661; E-mail: Lena{at}chem.umu.se.
1
The abbreviations used are: IPTG,
isopropyl- -D-thiogalactopyranoside; DTT, dithiothreitol;
MOPS, 2-(N-morpholino)propanesulfonic acid; NEM,
N-ethylmaleimide; CHAPS,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
2
L. Sahlman and J. Powlowski, unpublished
results.
ACKNOWLEDGEMENTS
We thank Eva-Maj Hägglöf and
Eleonore Granström Skärfstad for skilled
technical assistance, and Åke Wieslander for gifts of
substituted maleimides.
REFERENCES
-
Ni'Bhriain, N., and Foster, T. J.
(1986)
Gene (Amst.)
42,
323-330
[CrossRef][Medline]
[Order article via Infotrieve]
-
Foster, T. J., Nakahara, H., Weiss, A. A., and Silver, S.
(1979)
J. Bacteriol.
140,
167-181
[Abstract/Free Full Text]
-
Ni'Bhriain, N. N., Silver, S., and Foster, T. J.
(1983)
J. Bacteriol.
155,
690-703
[Abstract/Free Full Text]
-
Lund, P. A., Ford, S. J., and Brown, N. L.
(1986)
J. Gen. Microbiol.
132,
465-480
[Abstract/Free Full Text]
-
Mukhopadhyay, D., Yu, H. R., Nucifora, G., and Misra, T. K.
(1991)
J. Biol. Chem.
266,
18538-18542
[Abstract/Free Full Text]
-
Nakahara, H., Silver, S., Miki, T., and Rownd, R. H.
(1979)
J. Bacteriol.
140,
161-166
[Abstract/Free Full Text]
-
Barrineau, P., Gilbert, P., Jackson, W. J., Jones, C. S., Summers, A. O., and Wisdom, S.
(1984)
J. Mol. Appl. Genet.
2,
601-619
[Medline]
[Order article via Infotrieve]
-
Misra, T. K., Brown, N. L., Fritzinger, D. C., Pridmore, R. D., Barnes, W. M., Haberstroh, L., and Silver, S.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
5975-5979
[Abstract/Free Full Text]
-
Misra, T. K., Brown, N. L., Haberstroh, L., Schmidt, A., Godette, D., and Silver, S.
(1985)
Gene (Amst.)
34,
253-262
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jackson, W. J., and Summers, A. O.
(1982)
J. Bacteriol.
149,
479-487
[Abstract/Free Full Text]
-
Jackson, W. J., and Summers, A. O.
(1982)
J. Bacteriol.
151,
962-970
[Abstract/Free Full Text]
-
Ames, G. F.-L., Mimura, C. S., and Shyamala, V.
(1990)
FEMS Microbiol. Rev.
75,
429-446
[CrossRef]
-
Higgins, C. F.
(1992)
Annu. Rev. Cell Biol.
8,
67-113
[CrossRef]
-
Shuman, H. A., and Panagiotidis, C. H.
(1993)
J. Bioenerg. Biomembr.
25,
613-620
[Medline]
[Order article via Infotrieve]
-
Brown, N. L.
(1985)
Trends Biochem. Sci.
10,
400-403
[CrossRef]
-
Morby, A. P., Hobman, J. L., and Brown, N. L.
(1995)
Mol. Microbiol.
17,
25-35
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hobman, J. L., and Brown, N. L.
(1996)
Mol. Gen. Genet.
250,
129-134
[Medline]
[Order article via Infotrieve]
-
Hamlett, N. V., Landale, E. C., Davis, B. H., and Summers, A. O.
(1992)
J. Bacteriol.
174,
6377-6385
[Abstract/Free Full Text]
-
Lund, P. A., and Brown, N. L.
(1987)
Gene (Amst.)
52,
207-214
[CrossRef][Medline]
[Order article via Infotrieve]
-
Inoue, C., Sugawara, K., and Kusano, T.
(1990)
Gene (Amst.)
96,
115-120
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kusano, T., Ji, G., Inoue, C., and Silver, S.
(1990)
J. Bacteriol.
172,
2688-2692
[Abstract/Free Full Text]
-
Inoue, C., Kusano, T., and Silver, S.
(1996)
Biosci. Biotech. Biochem.
60,
1289-1292
[Medline]
[Order article via Infotrieve]
-
Sahlman, L., and Jonsson, B.-H.
(1992)
Eur. J. Biochem.
205,
375-381
[Medline]
[Order article via Infotrieve]
-
Sahlman, L., and Skärfstad, E. G.
(1993)
Biochem. Biophys. Res. Commun.
196,
583-588
[CrossRef][Medline]
[Order article via Infotrieve]
-
Eriksson, P.-O., and Sahlman, L.
(1993)
J. Biomol. NMR
3,
613-626
[Medline]
[Order article via Infotrieve]
-
Steele, R. A., and Opella, S. J.
(1997)
Biochemistry
36,
6885-6985
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nair, S. K., Calderone, T. L., Christianson, D. W., and Fierke, C. A.
(1991)
J. Biol. Chem.
266,
17320-17325
[Abstract/Free Full Text]
-
Rosenberg, A. H., Lade, B. N., Chui, D.-S., Lin, S.-W., Dunn, J. J., and Studier, F. W.
(1987)
Gene (Amst.)
56,
125-135
[CrossRef][Medline]
[Order article via Infotrieve]
-
Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W.
(1990)
Methods Enzymol.
185,
60-89
[Medline]
[Order article via Infotrieve]
-
Sambrook, J., Fritsch, E. F., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
-
Kaback, H. R.
(1971)
Methods Enzymol.
22,
99-120
[CrossRef]
-
Witholt, B., Boekhout, M., Brock, M., Kingma, J., van Heerikhuizen, H., and de Leij, L.
(1976)
Anal. Biochem.
74,
160-170
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kim, Y. J., Rajapandi, T., and Oliver, D.
(1994)
Cell
78,
845-853
[CrossRef][Medline]
[Order article via Infotrieve]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[CrossRef][Medline]
[Order article via Infotrieve]
-
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C.
(1985)
Anal. Biochem.
150,
76-85
[CrossRef][Medline]
[Order article via Infotrieve]
-
Riddles, P. W., Blakely, R. L., and Zerner, B.
(1983)
Methods Enzymol.
91,
49-60
[Medline]
[Order article via Infotrieve]
-
Jones, P. C., Sivaprasadarao, A., Wray, D., and Findlay, J. B. C.
(1996)
Mol. Membr. Biol.
13,
53-60
[Medline]
[Order article via Infotrieve]
-
Prossnitz, E., Gee, A., and Ames, G. F.-L.
(1989)
J. Biol. Chem.
264,
5006-5014
[Abstract/Free Full Text]
-
Claros, M. G., and von Heijne, G.
(1994)
Comput. Appl. Biosci.
10,
685-686
[Free Full Text]
-
von Heijne, G.
(1992)
J. Mol. Biol.
225,
487-494
[CrossRef][Medline]
[Order article via Infotrieve]
-
Selifonova, O. V., and Barkay, T.
(1994)
Appl. Environ. Microbiol.
60,
3503-3507
[Abstract/Free Full Text]
-
Bull, P. C., and Cox, D. W.
(1994)
Trends Genet.
10,
246-252
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fox, B. S., and Walsh, C. T.
(1983)
Biochemistry
22,
4082-4088
[CrossRef][Medline]
[Order article via Infotrieve]
-
Foster, D. L., Boublik, M., and Kaback, H. R.
(1983)
J. Biol. Chem.
258,
31-34
[Abstract/Free Full Text]
-
Summers, A. O.
(1986)
Annu. Rev. Microbiol.
40,
607-634
[CrossRef][Medline]
[Order article via Infotrieve]
-
Girault, L., Lemaire, P., Boudou, A., Debouzy, J.-C., and Dufourc, E. J.
(1996)
Eur. Biophys. J.
24,
413-421
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gutknecht, J.
(1981)
J. Membr. Biol.
61,
61-66
[CrossRef]
-
Utschig, L. M., Wright, J. G., and O'Halloran, T. V.
(1993)
Methods Enzymol.
226,
71-97
[Medline]
[Order article via Infotrieve]
Volume 272, Number 47,
Issue of November 21, 1997
pp. 29518-29526
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Thilakaraj, K. Raghunathan, S. Anishetty, and G. Pennathur
In silico identification of putative metal binding motifs
Bioinformatics,
February 1, 2007;
23(3):
267 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schneiker, M. Keller, M. Droge, E. Lanka, A. Puhler, and W. Selbitschka
The genetic organization and evolution of the broad host range mercury resistance plasmid pSB102 isolated from a microbial population residing in the rhizosphere of alfalfa
Nucleic Acids Res.,
December 15, 2001;
29(24):
5169 - 5181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Powlowski and L. Sahlman
Reactivity of the Two Essential Cysteine Residues of the Periplasmic Mercuric Ion-binding Protein, MerP
J. Biol. Chem.,
November 19, 1999;
274(47):
33320 - 33326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Liebert, R. M. Hall, and A. O. Summers
Transposon Tn21, Flagship of the Floating Genome
Microbiol. Mol. Biol. Rev.,
September 1, 1999;
63(3):
507 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|